Trans-ethnic association study of blood pressure determinants in over 750,000 individuals

Nature Genetics

Volumn 51, Issue 1, 2019, Pages 51-62

  Giri, Ayush ^a,b   Hellwege, Jacklyn N ^a,b   Keaton, Jacob M ^a,b   Park, Jihwan ^c   Qiu, Chengxiang ^c   Warren, Helen R ^d,e   Torstenson, Eric S ^a,b   Kovesdy, Csaba P ^f   Sun, Yan V ^g,h   Wilson, Otis D ^a,b   Robinson Cohen, Cassianne ^a   Roumie, Christianne L ^a,i   Chung, Cecilia P ^a   Birdwell, Kelly A ^a,j   Damrauer, Scott M ^i,k   DuVall, Scott L ^i,l   Klarin, Derek ^i,m,n   Cho, Kelly ^o,p,q   Wang, Yu ^a   Evangelou, Evangelos ^r,s   Cabrera, Claudia P ^d,e   Wain, Louise V ^t,u   Shrestha, Rojesh ^c   Mautz, Brian S ^a   Akwo, Elvis A ^a   Sargurupremraj, Muralidharan ^v   Debette, Stéphanie ^v,w   Boehnke, Michael ^x   Scott, Laura J ^x   Luan, Jian’an ^y   Zhao, Jing Hua ^y   Willems, Sara M ^y   Thériault, Sébastien ^z,aa   Shah, Nabi ^ab,ac   Oldmeadow, Christopher ^ad   Almgren, Peter ^ae   Li Gao, Ruifang ^af   Verweij, Niek ^ag   Boutin, Thibaud S ^ah   Mangino, Massimo ^ai,aj   Ntalla, Ioanna ^d   Feofanova, Elena ^ak   Surendran, Praveen ^al   Cook, James P ^am   Karthikeyan, Savita ^al   Lahrouchi, Najim ^m,n,an   Liu, Chunyu ^ao   Sepúlveda, Nuno ^ap   Richardson, Tom G ^aq   Kraja, Aldi ^ar   Amouyel, Philippe ^as   Farrall, Martin ^at   Poulter, Neil R ^r   Laakso, Markku ^au   Zeggini, Eleftheria ^av   Sever, Peter ^aw   Scott, Robert A ^y   Langenberg, Claudia ^y   Wareham, Nicholas J ^y   Conen, David ^ax   Palmer, Colin Neil Alexander ^ab   Attia, John ^ad,ay   Chasman, Daniel I ^p   Ridker, Paul M ^p   Melander, Olle ^ae   Mook Kanamori, Dennis Owen ^af   van der Harst, Pim ^ag   Cucca, Francesco ^az,ba   Schlessinger, David ^bb   Hayward, Caroline ^ah   Spector, Tim D ^ai   Jarvelin, Marjo Riitta ^{r,bc,bd,be,bf}   Hennig, Branwen J ^ap,bg,bh   Timpson, Nicholas J ^aq   Wei, Wei Qi ^a   Smith, Joshua C ^a   Xu, Yaomin ^a   Matheny, Michael E ^a,i   Siew, Edward E ^a,i   Lindgren, Cecilia ^n,at,bi   Herzig, Karl Heinz ^be,bj   Dedoussis, George ^bk   Denny, Joshua C ^a   Psaty, Bruce M ^bl,bm   Howson, Joanna M M ^al   Munroe, Patricia B ^d,e   Newton Cheh, Christopher ^m   Caulfield, Mark J ^d,e   Elliott, Paul ^r,bn   Gaziano, J Michael ^o,p   Concato, John ^bo,bp   Wilson, Peter W F ^bq,br   Tsao, Philip S ^bs,bt   Velez Edwards, Digna R ^a,b   Susztak, Katalin ^c,k   O’Donnell, Christopher J ^p,bu   Hung, Adriana M ^a,b   Edwards, Todd L ^a,b   more..

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g EMORY UNIVERSITY   (United States)

^h EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ VETERANS AFFAIRS MEDICAL CENTER   (United States)

^j Tennessee Valley Healthcare System   (United States)

^k UNIVERSITY OF PENNSYLVANIA   (United States)

^l UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^m MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁿ BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^o VA BOSTON HEALTHCARE SYSTEM   (United States)

^p BRIGHAM AND WOMEN S HOSPITAL   (United States)

^q HARVARD MEDICAL SCHOOL   (United States)

^r IMPERIAL COLLEGE LONDON   (United Kingdom)

^s UNIVERSITY OF IOANNINA   (Greece)

^t UNIVERSITY OF LEICESTER   (United Kingdom)

^u GLENFIELD HOSPITAL   (United Kingdom)

^v UNIVERSITÉ DE BORDEAUX   (France)

^w BORDEAUX UNIVERSITY HOSPITAL   (France)

^x UNIVERSITY OF MICHIGAN   (United States)

^y UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^z MCMASTER UNIVERSITY   (Canada)

^aa UNIVERSITÉ LAVAL   (Canada)

^ab UNIVERSITY OF DUNDEE   (United Kingdom)

^ac University of Dundee ^*  (Pakistan)

^ad HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^ae LUND UNIVERSITY   (Sweden)

^af LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^ag UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^ah UNIVERSITY OF EDINBURGH   (United Kingdom)

^ai KING'S COLLEGE LONDON   (United Kingdom)

^aj BHF Centre for Regenerative Medicine and BHF Centre of Excellence and the Biomedical Research Centre at Guy s St Thomas NHS Foundation Trust and King s College London   (United Kingdom)

^ak UNIVERSITY OF TEXAS   (United States)

^al UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^am UNIVERSITY OF LIVERPOOL   (United Kingdom)

^an UNIVERSITY OF AMSTERDAM   (Netherlands)

^ao BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^ap LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^aq UNIVERSITY OF BRISTOL   (United Kingdom)

^ar WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^as UNIV LILLE   (France)

^at UNIVERSITY OF OXFORD   (United Kingdom)

^au UNIVERSITY OF EASTERN FINLAND   (Finland)

^av WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^aw NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^ax MCMASTER UNIVERSITY   (Canada)

^ay UNIVERSITY OF NEWCASTLE   (Australia)

^az Milan Unit   (Italy)

^ba UNIVERSITY OF SASSARI   (Italy)

^bb NATIONAL INSTITUTE ON AGING   (United States)

^bc UNIVERSITY OF OULU   (Finland)

^bd UNIVERSITY OF OULU   (Finland)

^be OULU UNIVERSITY HOSPITAL   (Finland)

^bf BRUNEL UNIVERSITY   (United Kingdom)

^bg WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^bh MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^bi UNIVERSITY OF OXFORD   (United Kingdom)

^bj POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^bk HAROKOPIO UNIVERSITY   (Greece)

^bl UNIVERSITY OF WASHINGTON   (United States)

^bm KAISER PERMANENTE   (United States)

^bn IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^bo VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^bp YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^bq ATLANTA VA MEDICAL CENTER   (United States)

^br EMORY UNIVERSITY   (United States)

^bs VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^bt STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^bu General Internal Medicine   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME;

ADOLESCENT; ANIMAL; BLOOD PRESSURE; ETHNIC GROUP; FEMALE; GENE EXPRESSION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HUMAN; KIDNEY TUBULE; MALE; MIDDLE AGED; MOUSE; PHYSIOLOGY; PROCEDURES; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION;

ADOLESCENT; ANIMALS; BLOOD PRESSURE; ETHNIC GROUPS; FEMALE; GENE EXPRESSION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; KIDNEY TUBULES; MALE; MICE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSCRIPTOME; UP-REGULATION;

EID: 85058906993     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/s41588-018-0303-9     Document Type: Article

References (101)

1. Lawes, C. M. M., Vander Hoorn, S. & Rodgers, A. International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet 371, 1513–1518 (2008)
2. Forouzanfar, M. H. et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990-2015. JAMA 317, 165–182 (2017)
3. Lewington, S. et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360, 1903–1913 (2002)
4. Whelton, P. K. et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 71, e127–e248 (2017)
5. Muntner, P. et al. Potential U.S. population impact of the 2017 ACC/AHA high blood pressure guideline. J. Am. Coll. Cardiol. 71, 109–118 (2018)
6. International Consortium for Blood Pressure Genome-Wide Association Studies et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 478, 103–109 (2011)
7. Levy, D. et al. Genome-wide association study of blood pressure and hypertension. Nat. Genet. 41, 677–687 (2009)
8. Newton-Cheh, C. et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat. Genet. 41, 666–676 (2009)
9. Franceschini, N. et al. Genome-wide association analysis of blood-pressure traits in African-ancestry individuals reveals common associated genes in African and non-African populations. Am. J. Hum. Genet. 93, 545–554 (2013)
10. Liang, J. et al. Single-trait and multi-trait genome-wide association analyses identify novel loci for blood pressure in African-ancestry populations. PLoS Genet. 13, e1006728 (2017)
11. Li, C. et al. Genome-wide association study meta-analysis of long-term average blood pressure in East Asians. Circ. Cardiovasc. Genet. 10, e001527 (2017)
12. Warren, H. R. et al. Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk. Nat. Genet. 49, 403–415 (2017)
13. Sofer, T. et al. Genome-wide association study of blood pressure traits by Hispanic/Latino background: the Hispanic Community Health Study/Study of Latinos. Sci. Rep. 7, 10348 (2017)
14. Adeyemo, A. et al. A genome-wide association study of hypertension and blood pressure in African Americans. PLoS Genet. 5, e1000564 (2009)
15. Parmar, P. G. et al. International genome-wide association study consortium identifies novel loci associated with blood pressure in children and adolescents. Circ. Cardiovasc. Genet. 9, 266–278 (2016)
16. Lu, X. et al. Genome-wide association study in Chinese identifies novel loci for blood pressure and hypertension. Hum. Mol. Genet. 24, 865–874 (2015)
17. He, J. et al. Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese. Circ. Cardiovasc. Genet. 6, 598–607 (2013)
18. Kato, N. et al. Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians. Nat. Genet. 43, 531–538 (2011)
19. Kato, N. et al. Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation. Nat. Genet. 47, 1282–1293 (2015)
20. Kelly, T. N. et al. Genome-wide association study meta-analysis reveals transethnic replication of mean arterial and pulse pressure loci. Hypertension 62, 853–859 (2013)
21. Wain, L. V. et al. Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat. Genet. 43, 1005–1011 (2011)
22. Kraja, A. T. et al. New blood pressure-associated loci identified in meta-analyses of 475,000 individuals. Circ. Cardiovasc. Genet. 10, e001778 (2017)
23. Surendran, P. et al. Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension. Nat. Genet. 48, 1151–1161 (2016)
24. Liu, C. et al. Meta-analysis identifies common and rare variants influencing blood pressure and overlapping with metabolic trait loci. Nat. Genet. 48, 1162–1170 (2016)
25. Wain, L. V. et al. Novel blood pressure locus and gene discovery using genome-wide association study and expression data sets from blood and the kidney. Hypertension 70, e4–e19 (2017)
26. Ehret, G. B. et al. The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals. Nat. Genet. 48, 1171–1184 (2016)
27. Hoffmann, T. J. et al. Genome-wide association analyses using electronic health records identify new loci influencing blood pressure variation. Nat. Genet. 49, 54–64 (2017)
28. Lee, D. et al. A method to predict the impact of regulatory variants from DNA sequence. Nat. Genet. 47, 955–961 (2015)
29. Finucane, H. K. et al. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat. Genet. 47, 1228–1235 (2015)
30. Gusev, A. et al. Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases. Am. J. Hum. Genet. 95, 535–552 (2014)
31. Barbeira, A. N. et al. Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics. Nat. Commun. 9, 1825 (2018)
32. Gamazon, E. R. et al. A gene-based association method for mapping traits using reference transcriptome data. Nat. Genet. 47, 1091–1098 (2015)
33. Gusev, A. et al. Integrative approaches for large-scale transcriptome-wide association studies. Nat. Genet. 48, 245–252 (2016)
34. Zhu, Z. et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat. Genet. 48, 481–487 (2016)
35. International Consortium for Blood Pressure Genome-Wide Association Studies et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 478, 103–109 (2011)
36. GTEx Consortium. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 348, 648–660 (2015)
37. Ko, Y.-A. et al. Genetic-variation-driven gene-expression changes highlight genes with important functions for kidney disease. Am. J. Hum. Genet. 100, 940–953 (2017)
38. Uhlén, M. et al. Tissue-based map of the human proteome. Science 347, 1260419 (2015)
39. Pers, T. H. et al. Biological interpretation of genome-wide association studies using predicted gene functions. Nat. Commun. 6, 5890 (2015)
40. Gamazon, E. R. et al. Using an atlas of gene regulation across 44 human tissues to inform complex disease- and trait-associated variation. Nat. Genet. 50, 956–967 (2018)
41. Matsuki, K., Hathaway, C. K., Lawrence, M. G., Smithies, O. & Kakoki, M. The role of transforming growth factor β1 in the regulation of blood pressure. Curr. Hypertens. Rev. 10, 223–238 (2014)
42. Lavoie, P. et al. Neutralization of transforming growth factor-beta attenuates hypertension and prevents renal injury in uremic rats. J. Hypertens. 23, 1895–1903 (2005)
43. Dubois, C. M., Laprise, M. H., Blanchette, F., Gentry, L. E. & Leduc, R. Processing of transforming growth factor beta 1 precursor by human furin convertase. J. Biol. Chem. 270, 10618–10624 (1995)
44. Li, N. et al. Associations between genetic variations in the FURIN gene and hypertension. BMC Med. Genet. 11, 124 (2010)
45. Ruschitzka, F. et al. Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial. Eur. Heart J. 38, 3282–3292 (2017)
46. Rippe, C. et al. Hypertension reduces soluble guanylyl cyclase expression in the mouse aorta via the Notch signaling pathway. Sci. Rep. 7, 1334 (2017)
47. Bauersachs, J. et al. Vasodilator dysfunction in aged spontaneously hypertensive rats: changes in NO synthase III and soluble guanylyl cyclase expression, and in superoxide anion production. Cardiovasc. Res. 37, 772–779 (1998)
48. Ruetten, H., Zabel, U., Linz, W. & Schmidt, H. H. Downregulation of soluble guanylyl cyclase in young and aging spontaneously hypertensive rats. Circ. Res. 85, 534–541 (1999)
49. Protogerou, A. D. et al. Longitudinal changes in mean and pulse pressure, and all-cause mortality: data from 71,629 untreated normotensive individuals. Am. J. Hypertens. 30, 1093–1099 (2017)
50. Yasuno, S. et al. Is pulse pressure a predictor of new-onset diabetes in high-risk hypertensive patients? Diabetes Care 33, 1122–1127 (2010)
51. Said, M. A., Eppinga, R. N., Lipsic, E., Verweij, N. & van der Harst, P. Relationship of arterial stiffness index and pulse pressure with cardiovascular disease and mortality. J. Am. Heart Assoc. 7, e007621 (2018)
52. Prenner, S. B. & Chirinos, J. A. Arterial stiffness in diabetes mellitus. Atherosclerosis 238, 370–379 (2015)
53. Xu, M. et al. Diabetes and risk of arterial stiffness: a Mendelian randomization analysis. Diabetes 65, 1731–1740 (2016)
54. Bhosale, S. D. et al. Serum proteomic profiling to identify biomarkers of premature carotid atherosclerosis. Sci. Rep. 8, 9209 (2018)
55. Lee, J. H. et al. Association between CDH13 variants and cardiometabolic and vascular phenotypes in a Korean population. Yonsei. Med. J. 54, 1305–1312 (2013)
56. Reschen, M. E., Lin, D., Chalisey, A., Soilleux, E. J. & O’Callaghan, C. A. Genetic and environmental risk factors for atherosclerosis regulate transcription of phosphatase and actin regulating gene PHACTR1. Atherosclerosis 250, 95–105 (2016)
57. Jarray, R. et al. Disruption of phactr-1 pathway triggers pro-inflammatory and pro-atherogenic factors: new insights in atherosclerosis development. Biochimie 118, 151–161 (2015)
58. Williams, C., Kingwell, B. A., Burke, K., McPherson, J. & Dart, A. M. Folic acid supplementation for 3 wk reduces pulse pressure and large artery stiffness independent of MTHFR genotype. Am. J. Clin. Nutr. 82, 26–31 (2005)
59. Girelli, D. et al. The interaction between MTHFR 677 C→T genotype and folate status is a determinant of coronary atherosclerosis risk. J. Nutr. 133, 1281–1285 (2003)
60. Rapsomaniki, E. et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people. Lancet 383, 1899–1911 (2014)
61. Bani, D. Relaxin: a pleiotropic hormone. Gen. Pharmacol. 28, 13–22 (1997)
62. Grossman, J. & Frishman, W. H. Relaxin: a new approach for the treatment of acute congestive heart failure. Cardiol. Rev. 18, 305–312 (2010)
63. Teichman, S. L. et al. Relaxin, a pleiotropic vasodilator for the treatment of heart failure. Heart. Fail. Rev. 14, 321–329 (2009)
64. Teerlink, J. R. et al. Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study. Lancet 373, 1429–1439 (2009)
65. Bathgate, Ra. D. et al. Relaxin family peptides and their receptors. Physiol. Rev. 93, 405–480 (2013)
66. McNally, T. et al. Cloning and expression of the adenosine kinase gene from rat and human tissues. Biochem. Biophys. Res. Commun. 231, 645–650 (1997)
67. Shryock, J. C. & Belardinelli, L. Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am. J. Cardiol. 79, 2–10 (1997)
68. Böhm, M. Cardiac effects of adenosine. Mechanism of action, pathophysiologic and clinical significance. Klin. Wochenschr. 65, 487–499 (1987)
69. Echavarría-Pinto, M. et al. Low coronary microcirculatory resistance associated with profound hypotension during intravenous adenosine infusion: implications for the functional assessment of coronary stenoses. Circ. Cardiovasc. Interv. 7, 35–42 (2014)
70. Camm, A. J. & Garratt, C. J. Adenosine and supraventricular tachycardia. N. Engl. J. Med. 325, 1621–1629 (1991)
71. Shen, F. M. & Su, D. F. The effect of adenosine on blood pressure variability in sinoaortic denervated rats is mediated by adenosine A2a-receptor. J. Cardiovasc. Pharmacol. 36, 681–686 (2000)
72. Maass, P. G. et al. PDE3A mutations cause autosomal dominant hypertension with brachydactyly. Nat. Genet. 47, 647–653 (2015)
73. Houslay, M. Hypertension linked to PDE3A activation. Nat. Genet. 47, 562–563 (2015)
74. Schuster, H. et al. A cross-over medication trial for patients with autosomal-dominant hypertension with brachydactyly. Kidney Int. 53, 167–172 (1998)
75. Naraghi, R. et al. Neurovascular compression at the ventrolateral medulla in autosomal dominant hypertension and brachydactyly. Stroke 28, 1749–1754 (1997)
76. Schunkert, H. et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat. Genet. 43, 333–338 (2011)
77. Getman, D. K., Eubanks, J. H., Camp, S., Evans, G. A. & Taylor, P. The human gene encoding acetylcholinesterase is located on the long arm of chromosome 7. Am. J. Hum. Genet. 51, 170–177 (1992)
78. Singer, W. et al. Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension. J. Neurol. Neurosurg. Psychiatry 74, 1294–1298 (2003)
79. Del Greco, M. F. et al. Genome-wide association analysis and fine mapping of NT-proBNP level provide novel insight into the role of the MTHFR-CLCN6-NPPA-NPPB gene cluster. Hum. Mol. Genet. 20, 1660–1671 (2011)
80. Flister, M. J. et al. Identifying multiple causative genes at a single GWAS locus. Genome Res. 23, 1996–2002 (2013)
81. Potter, L. R., Yoder, A. R., Flora, D. R., Antos, L. K. & Dickey, D. M. Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications. Handb. Exp. Pharmacol. 341–366 (2009)
82. Brandt, S. & Jentsch, T. J. ClC-6 and ClC-7 are two novel broadly expressed members of the CLC chloride channel family. FEBS Lett. 377, 15–20 (1995)
83. Park, J. et al. Comprehensive single cell RNAseq analysis of the kidney reveals novel cell types and unexpected cell plasticity. Preprint at https://www.biorxiv.org/content/early/2017/10/13/203125 (2017)
84. Manichaikul, A. et al. Robust relationship inference in genome-wide association studies. Bioinformatics 26, 2867–2873 (2010)
85. The 1000 Genomes Project Consortium. A global reference for human genetic variation. Nature 526, 68–74 (2015)
86. Loh, P.-R. et al. Reference-based phasing using the Haplotype Reference Consortium panel. Nat. Genet. 48, 1443–1448 (2016)
87. Das, S. et al. Next-generation genotype imputation service and methods. Nat. Genet. 48, 1284–1287 (2016)
88. Abraham, G. & Inouye, M. Fast principal component analysis of large-scale genome-wide data. PLoS One 9, e93766 (2014)
89. Chawla, P. S. & Kochar, M. S. Effect of pain and nonsteroidal analgesics on blood pressure. WMJ 98, 22–25 (1999). 29
90. Maixner, W., Gracely, R. H., Zuniga, J. R., Humphrey, C. B. & Bloodworth, G. R. Cardiovascular and sensory responses to forearm ischemia and dynamic hand exercise. Am. J. Physiol. 259, R1156–R1163 (1990)
91. Taylor, J. Y. et al. A genome-wide study of blood pressure in African Americans accounting for gene-smoking interaction. Sci. Rep. 6, 18812 (2016)
92. Marchini, J., Howie, B., Myers, S., McVean, G. & Donnelly, P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet. 39, 906–913 (2007)
93. Bulik-Sullivan, B. K. et al. LD score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291–295 (2015)
94. Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190–2191 (2010)
95. Yang, J., Lee, S. H., Goddard, M. E. & Visscher, P. M. GCTA: a tool for genome-wide complex trait analysis. Am. J. Hum. Genet. 88, 76–82 (2011)
96. Denny, J. C. et al. PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene–disease associations. Bioinformatics 26, 1205–1210 (2010)
97. Carroll, R. J., Bastarache, L. & Denny, J. C. R. PheWAS: data analysis and plotting tools for phenome-wide association studies in the Renvironment. Bioinformatics 30, 2375–2376 (2014)
98. Kuhn, M., Letunic, I., Jensen, L. J. & Bork, P. The SIDER database of drugs and side effects. Nucleic Acids Res. 44, D1075–D1079 (2016)
99. Smith, J. C. et al. Lessons learned from developing a drug evidence base to support pharmacovigilance. Appl. Clin. Inform. 4, 596–617 (2013)
100. Cotto, K. C. et al. DGIdb 3.0: a redesign and expansion of the drug-gene interaction database. Nucleic Acids Res. 46, D1068–D1073 (2017)
101. Li, Y. H. et al. Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics. Nucleic Acids Res. 46, D1121–D1127 (2018)